First Hospira Biosimilar mAb Approved in West Europe

Pfizer to Acquire Hospira for Nearly $17 Billion

Margaret Hamburg Announces She Will Step Down in March 2015

GlaxoSmithKline to Keep Vaccine Prices Low for Gavi Members

EMA Recommends Suspension of 700 Drugs Tested at GVK Site

Commercializing Cell Therapies: Lonza’s Eytan Abraham on Challenges and Rewards

Better equipment and automated processes will be key. So, too, will the right way of approaching outsourcing relationships.

Time to Share

Data sharing and a common data model can improve CRO partnerships and trial results.

Tech Ops for Hire

As CMOs shed their old toll processing role, sponsors can expect the right questions, proactive communication, and a firm grasp of risk management and tech transfer from contract service providers.